Lifting Comparison
Thermage uses diffuse monopolar RF; Ultherapy uses focal ultrasound with imaging. Compare evidence, limitations, recovery questions, and quote details.
In This Guide
Thermage uses diffuse monopolar RF; Ultherapy uses focal ultrasound with imaging. Compare evidence, limitations, recovery questions, and quote details.
Section 1 / 5
Neither is a universal winner. Thermage delivers monopolar radiofrequency more diffusely through dermal and subdermal tissue; Ultherapy places focal ultrasound treatment points at selected depths with real-time visualization. The useful choice depends on the assessed tissue concern, anatomy, treatment area, exact device, and plan.
A randomized, evaluator-blind split-face trial did compare the two technology classes. In 20 people followed for 180 days, both sides improved and the investigators found no statistically significant difference on their standardized laxity measure. Read the trial record (PMID 30531187) or our plain-language trial review. That small study does not prove that the current Thermage FLX and Ultherapy Prime platforms are equivalent, or that either suits every patient.
Section 2 / 5
| Check | Thermage FLX | Ulthera System / Prime |
|---|---|---|
| Energy pattern | Monopolar RF; broader heating rather than one fixed treatment depth | MFU-V; focal points at selected transducer depths |
| Visualization | No ultrasound imaging; the system monitors contact and impedance | Integrated ultrasound visualization |
| US record | FDA 510(k) K170758 | FDA 510(k) K233996 |
| What the record means | A device-specific US substantial-equivalence record with stated indications. A 510(k) is separate from PMA and is not a comparative ranking, a result guarantee, or proof of Korean authorization. |
Do not reduce Thermage to one exact depth or assume that reaching a named ultrasound depth is automatically better. Mechanism is only one part of a clinical decision.
Section 3 / 5
The 2019 randomized split-face study treated one side of each participant's face with monopolar RF and the other with MFU-V. Twenty people with mild-to-moderate laxity were followed for six months. Both sides improved on the study's measures, with no statistically significant between-side difference in standardized investigator ratings, satisfaction, or adverse events.
The within-person design is useful, but the sample was small and follow-up ended at 180 days. It did not establish one best device, a fixed result duration, a repeat interval, a standard combination sequence, or superiority for every anatomy. It also should not be stretched into a claim about every current tip, transducer, setting, or protocol.
Section 4 / 5
Temporary redness, swelling, tenderness, discomfort, or altered sensation may occur after energy-based treatment; the material risks differ with the device, area, settings, and individual. “No downtime” is not a guarantee. Ask what is expected, what would be unusual, and how to contact the treating clinic if symptoms are marked or persistent. For an emergency, use local emergency services rather than a booking messenger.
The different mechanisms do not by themselves prove that both treatments should be combined, which should come first, or how long to wait. A combination plan needs an individual assessment and a documented rationale; this guide does not prescribe a universal sequence or interval.
Section 5 / 5
Request the exact device, area, lines or REPs, tip or transducer, clinician, pain-control plan, tax, aftercare, follow-up, and cancellation terms in writing. Session time and reassessment are not fixed by the brand name alone. Compare quotes only when their treatment scope and inclusions match.
Use the current Delight pricing page for published clinic ranges. A market estimate is not a patient-specific quotation, and a US FDA record does not determine Korean availability or price.
FAQ
Yes. A randomized, evaluator-blind split-face trial in 20 people compared monopolar RF with MFU-V for 180 days. Both sides improved and no statistically significant between-side difference was found, but the small study does not establish a universal winner.
Neither is universally better. The decision depends on the tissue concern, anatomy, area, exact platform, planned settings, limitations, risks, and individual assessment.
They may be considered together in an individualized plan, but their different mechanisms do not prove a universal combination, order, or interval. Ask for the rationale and alternatives after assessment.
This cannot be fixed from the brand name or the 180-day comparison trial. Response and reassessment vary with the patient, area, device, settings, and clinical plan.
Compare the exact device, area, lines or REPs, consumables, clinician, tax, pain control, aftercare, and follow-up. A market range is not a final patient-specific quote.
Related Procedures
If you need more detail about treatment approach, recovery, or suitability, continue into these procedure pages.
Solta Medical · AccuREP Technology
Thermage FLX is a monopolar radiofrequency platform. Published studies report variable and generally modest tightening in selected patients; tip, area, settings, risks, recovery, and expectations require individual assessment. It does not guarantee jawline change or replace surgery or volume treatment.
Non-surgical Lifting
Ultherapy is a brand-name microfocused-ultrasound platform with imaging. Published studies report variable change in selected patients; candidate selection, anatomy, area, transducer, settings, risks, recovery, and expectations require individual assessment. It does not guarantee lifting or replace surgery.
Periorbital Tightening
Eye Thermage FLX in Seoul uses an eye-specific RF tip for mild eyelid laxity and fine lines. Review eye protection, risks, 25–35 min timing and downtime.
Anti-Aging Package
Neck tightening package in Seoul — Botox for platysmal bands plus filler for neck creases. Board-certified dermatologist in Gangnam.